UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study

The American heart journal, 2015-06, Vol.169 (6), p.906-915.e13

2015

Volltextzugriff (PDF)

Effect of Vaccination on Transmission of SARS-CoV-2

The New England journal of medicine, 2021-10, Vol.385 (18), p.1718-1720

2021

Volltextzugriff (PDF)

Relation of Incident Type 1 Diabetes to Recent COVID-19 Infection: Cohort Study Using e-Health Record Linkage in Scotland

Diabetes care, 2023-05, Vol.46 (5), p.921-928

2023

Volltextzugriff (PDF)

Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial

Atherosclerosis, 2016-01, Vol.244, p.138-146

2016

Volltextzugriff (PDF)

Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study

PLoS medicine, 2012-10, Vol.9 (10), p.e1001321-e1001321

2012

Volltextzugriff (PDF)

Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study

PLoS medicine, 2020-10, Vol.17 (10), p.e1003374-e1003374

2020

Volltextzugriff (PDF)

Biomarkers of rapid chronic kidney disease progression in type 2 diabetes

Kidney international, 2015-10, Vol.88 (4), p.888-896

2015

Volltextzugriff (PDF)

Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study

BMC medicine, 2021-02, Vol.19 (1), p.51-11, Article 51

2021

Volltextzugriff (PDF)

Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND

Cardiovascular diabetology, 2021-09, Vol.20 (1), p.194-194, Article 194

2021

Volltextzugriff (PDF)

Contemporary Risk of Hip Fracture in Type 1 and Type 2 Diabetes: A National Registry Study From Scotland

Journal of bone and mineral research, 2014-05, Vol.29 (5), p.1054-1060

2014

Volltextzugriff (PDF)

A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes

Diabetes care, 2021-04, Vol.44 (4), p.901-907

2021

Volltextzugriff (PDF)

Biomarkers of diabetic kidney disease

Diabetologia, 2018-05, Vol.61 (5), p.996-1011

2018

Volltextzugriff (PDF)

Association of cerebral venous thrombosis with recent COVID-19 vaccination: case-crossover study using ascertainment through neuroimaging in Scotland

BMC infectious diseases, 2021-12, Vol.21 (1), p.1275-1275, Article 1275

2021

Volltextzugriff (PDF)

Effect of serum sample storage temperature on metabolomic and proteomic biomarkers

Scientific reports, 2022-03, Vol.12 (1), p.4571-4571, Article 4571

2022

Volltextzugriff (PDF)

Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes

Diabetologia, 2015-06, Vol.58 (6), p.1363-1371

2015

Volltextzugriff (PDF)

Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study

BMC medicine, 2021-06, Vol.19 (1), p.1-149, Article 149

2021

Volltextzugriff (PDF)

Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study

PLoS medicine, 2019-10, Vol.16 (10), p.e1002945

2019

Volltextzugriff (PDF)

Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes

BMC medicine, 2019-08, Vol.17 (1), p.165-165, Article 165

2019

Volltextzugriff (PDF)

Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study

BMC nephrology, 2017-05, Vol.18 (1), p.163-8, Article 163

2017

Volltextzugriff (PDF)

Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies

Cardiovascular diabetology, 2019-11, Vol.18 (1), p.149-10, Article 149

2019

Volltextzugriff (PDF)

Cohort profile: the Scottish Diabetes Research Network national diabetes cohort – a population-based cohort of people with diabetes in Scotland

BMJ open, 2022-10, Vol.12 (10), p.e063046-e063046

2022

Volltextzugriff (PDF)

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis

The lancet. Diabetes & endocrinology, 2014-06, Vol.2 (6), p.481-487

2014

Volltextzugriff (PDF)

Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol

Cardiovascular diabetology, 2020-02, Vol.19 (1), p.14-14, Article 14

2020

Volltextzugriff (PDF)

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)

Journal of lipid research, 2012-05, Vol.53 (5), p.1000-1011

2012

Volltextzugriff (PDF)

Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial

European heart journal, 2015-05, Vol.36 (19), p.1186-1194

2015

Volltextzugriff (PDF)

1 – 25 von 277

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(247)

Publikationsform

Artikel
(276)
Buchkapitel
(1)

Sprache

Englisch
(277)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Diabetes Care
(38)
Diabetologia
(29)
Diabetes
(21)
Journal Of The American College Of Cardiology
(15)
The Lancet
(13)
Circulation
(8)
Diabetes, Obesity & Metabolism
(8)
Cardiovascular Diabetology
(7)
Lancet
(6)
The Lancet. Diabetes & Endocrinology
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study

Effect of Vaccination on Transmission of SARS-CoV-2

Relation of Incident Type 1 Diabetes to Recent COVID-19 Infection: Cohort Study Using e-Health Record Linkage in Scotland

Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial

Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study

Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study

Biomarkers of rapid chronic kidney disease progression in type 2 diabetes

Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study

Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND

Contemporary Risk of Hip Fracture in Type 1 and Type 2 Diabetes: A National Registry Study From Scotland

A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes

Biomarkers of diabetic kidney disease

Association of cerebral venous thrombosis with recent COVID-19 vaccination: case-crossover study using ascertainment through neuroimaging in Scotland

Effect of serum sample storage temperature on metabolomic and proteomic biomarkers

Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes

Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study

Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study

Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes

Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study

Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies

Cohort profile: the Scottish Diabetes Research Network national diabetes cohort – a population-based cohort of people with diabetes in Scotland

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis

Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)

Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial

Suchergebnisse filtern